|
Overview
|
Three Keynote Presentations
|
|
|
|
 |
Engaging Discovery Science with Development Early on in the Process
Frank Walsh, Ph.D., Senior Vice President, Discovery, Wyeth Research
|
Utilizing the Medical Affairs, R&D Relationship to Maximize Product Potential
Catherine M. Bonuccelli, M.D., Vice President, External Scientific Affairs,
AstraZeneca
|
How Best to Integrate Preclinical Discovery and Clinical Development
Jackie Hunter, Ph.D., Senior Vice President & Head, Neurology & GI Center of Excellence for Drug Discovery, GlaxoSmithKline
|
|
|
|
| Distinguished Presenters: |
|
Catherine M. Bonuccelli, M.D.
Vice President, External Scientific Affairs AstraZeneca
Andrew F. Branca
Senior Vice President & Group Leader
Cambridge Healthtech Advisors
Jackie Hunter, Ph.D.
Senior Vice President & Head, Neurology & GI Center of Excellence for Drug Discovery GlaxoSmithKline
Maureen Kiley
Director, New Product Planning
Eli Lilly and Company
David S. Lester
New York Site Head, Worldwide Clinical Technology Pfizer Global R&D
Steve J. Offord, Ph.D.
Head New Products CNS/ Thrombosis, Global Marketing & Medical Aventis
|
Richard Scheyer, M.D.
Senior Distinguished Scientist, Product Realization Aventis
John Wagner, M.D., Ph.D.
Senior Director, Department of Clinical Pharmacology, Merck Research Laboratories
Frank Walsh, Ph.D.
Senior Vice President, Discovery Wyeth Research
Janet White
Senior Director, Business Operations, La Jolla Development Pfizer Global Research & Development
Pre-Conference Tutorial-September 20, 2004
Bringing Different Functions Together:
Discovery–Development–Commercial Interactions Jan Malek, PA Consulting
|
About The Pharmaceutical Strategy Series
The Pharmaceutical Strategy Series (PSS) is a division of Cambridge Healthtech Institute. PSS programs have been designed to help the R&D leaders and corporate executives assess business opportunities, enhance corporate value and forecast the economic and regulatory landscape within the rapidly changing pharmaceutical & biotechnology industries. PSS chooses the most topical issues to cover, based largely on advice given by the PSS Advisory Board. The Advisory Board is comprised of decision-makers at most of the world’s leading pharmaceutical companies. Presentations in each Executive Forum will give you the ideas, information, and resources you need to make faster and smarter decisions. You can review an updated PSS schedule at
www.pharmaseries.com.
Call for Sponsors
CHI offers a variety of conference sponsorships designed to bring your
company face to face with key executive decision-makers, position your
solutions/services and increase revenue opportunities in a highly
competitive marketplace. You will interact with Vice Presidents, Heads of
Departments and Directors of Pharmaceutical and Biotechnology companies, who
will attend this focused executive forum.
For details, please contact:
Eric Glazer at 781-972-5442; email: eglazer@healthtech.com
|
